Proof-of concept study to evaluate the safety and analgesic efficacy of topical 3%-diclofenac-nano-emulsion cream versus placebo for knee osteoarthritis.

Trial Profile

Proof-of concept study to evaluate the safety and analgesic efficacy of topical 3%-diclofenac-nano-emulsion cream versus placebo for knee osteoarthritis.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2011

At a glance

  • Drugs Diclofenac (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Aug 2008 Status changed from recruiting to active, no longer recruiting according to Pharmos media release.
    • 08 May 2008 Patient recruitment is expected to be completed in mid 2008, as reported by Pharmos Corporation.
    • 02 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top